Loading fund overlap…
16 of 242 unique stocks in common · Jaccard: 6.6%
A weighted portfolio overlap of 18.73% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹18.73 is allocated to the exact same companies at the same relative proportions. The schemes share 16 common holdings.
The largest overlapping asset in their portfolios is Infosys, which commands a weight of 4.18% in Aditya Birla Sun Life ELSS Tax Saver Fund and 7.13% in UTI Nifty500 Shariah Index Fund. Holding both schemes increases your concentration in Infosys rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in UTI |
|---|---|---|
| InfosysIT - Software | 4.18% | 7.13% |
| Hindalco IndustriesNon - Ferrous Metals | 2.40% | 2.86% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.15% | 3.34% |
| Tech MahindraIT - Software | 2.36% | 1.65% |
| Cummins IndiaIndustrial Products | 2.19% | 1.39% |
| Ultratech CementCement & Cement Products | 1.18% | 2.38% |
| Avenue SupermartsRetailing | 1.51% | 1.05% |
| Hindustan UnileverDiversified FMCG | 1.00% | 3.35% |
| Fortis HealthcareHealthcare Services | 2.49% | 0.85% |
| Dixon Technologies (India)Consumer Durables | 0.95% | 0.83% |
| Persistent SystemsIT - Software | 0.74% | 0.99% |
| Godrej Consumer ProductsPersonal Products | 1.84% | 0.72% |
| Sai Life SciencesPharmaceuticals & Biotechnology | 0.52% | 0.28% |
| Gillette IndiaPersonal Products | 1.31% | 0.11% |
| Whirlpool of IndiaConsumer Durables | 0.45% | 0.11% |
| Emcure PharmaceuticalsPharmaceuticals & Biotechnology | 1.58% | 0.10% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.